In particular, interferons and inflammation-related genes could suggest a link between MAPT expression and inhibition of anti-tumor immune response, with possible therapeutic implications given the fast-paced clinical implementation of the immunotherapy58. The gene discussed is MAPT; the disease is neoplasm.